ClinicalTrials.Veeva

Menu

Q Value Customized Versus Wavefront Optimized Ablation in Femtosecond Laser-Assisted LASIK

A

Assiut University

Status

Completed

Conditions

Patients With Myopic Spherical Equivalent up to -12 Diopters

Treatments

Procedure: Femtosecond laser assisted LASIK eye surgery

Study type

Interventional

Funder types

Other

Identifiers

NCT04738903
CQLASIK

Details and patient eligibility

About

Corneal asphericity is expressed numerically as the "Q-value". A minus value means that corneal curvature flattens towards the periphery and the cornea is prolate in shape, but when the curvature steepens towards the periphery, the cornea is oblate in shape and has a positive Q-value.

The current study evaluates the effect of LASIK eye surgery on corneal asphericity by comparing 2 software treatment platforms; the Q value customized ablation versus the conventional Wave-front optimized ablation in a fellow eye study pattern.

Full description

The standard excimer laser correction of myopia is associated with decreased visual quality in the form of a decrease in contrast sensitivity and night vision. This degradation of the visual quality is attributed to changes in the corneal asphericity that increase the high order aberrations (HOAs), such as spherical aberrations because it leads to shifting of the corneal asphericity towards the oblate shape.

The wavefront-optimized (WFO) profile avoids the creation of new HOAs, but it is not able to treat those which are already present pre-operatively.

The Q-adjusted treatments correct the sphero-cylindrical refractive errors and try to maintain the corneal asphericity at the same time, but like the WFO ablation profiles, it is limited to correcting the spherical aberrations and not the non-rotational symmetric HOAs.

Some studies compared Lasers of two different platforms on contralateral eyes of the same patient in order to minimize inter-patient differences such as corneal wound healing and corneal biomechanics. By exclusion of these inter-patient differences, a more accurate judgment on the outcomes can be achieved.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Candidates for Laser vision correction (LVC) with

  1. Myopic Spherical Equivalent up to -12 diopters.
  2. Myopic astigmatism up to -6 diopters.
  3. Corneal thinnest location ≥ 500 um 4- Residual stromal bed ≥ 300 um.

Exclusion Criteria:

  1. Patients not candidates for LVC.
  2. Hyperopic patients or mixed astigmatism.
  3. Systemic disease that contraindicates LVC.
  4. Intra- or post-operative complications. 5- Previous corneal surgery

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

Custom Q treatment group
Active Comparator group
Description:
For every patient, the eye with the greater myopic spherical equivalent (SE) will be assigned for the Custom-Q treatment group.
Treatment:
Procedure: Femtosecond laser assisted LASIK eye surgery
Wave-front optimized (WFO) group
Active Comparator group
Description:
For every patient, the other eye with the lesser myopic SE will be assigned for the WFO treatment group
Treatment:
Procedure: Femtosecond laser assisted LASIK eye surgery

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems